Top 20 Cannabis Angel Investors in Canada in April 2025

Last updated: Apr 2025 A list of 20 angel investors that invest in Cannabis startups based in Canada. We rank investors based on the number of investments they made in Cannabis companies from Canada. We update this investor list every month.

Top 20 Cannabis Angel Investors in Canada in April 2025

Investor	Cannabis Canada investments
James Pardieck	1
Kathia Cambron	1
Chuck Rifici	1
John Nemanic	1
Ethan Oren Perlstein	1
Brett Wilson	1
Lanny Lipson	1
Jon Oringer	1
Monroe Asami	1
Nadav Ben-Chanoch	1
Jon Oringer	1
Kevin Liles	1
Aubrey Graham (Drake)	1
Tomas Lestrup	1
Ken Miyoshi	1
Robin Knox	1
Brett Wilson	1
Philip Sane	1
Jon Oringer	1
Aman Chatha	1

Find investors that fund startups like yours. Automatically.

Our algorithm will find investors that invest in your industry, stage, and geography.

Investor list

James Pardieck

Investment focus

Cannabis, Craft Beer, Food Processing
Seed
Canada

Portfolio highlights

Province Brands of Canada — We are your sustainable and plant-based sweetener solution. We upcycle plant-waste biomass and transform it into food-grade sugars.

Kathia Cambron

Investment focus

Cannabis, Craft Beer, Food Processing
Seed
Canada

Portfolio highlights

Province Brands of Canada — We are your sustainable and plant-based sweetener solution. We upcycle plant-waste biomass and transform it into food-grade sugars.

Dubbed the ‘Willy Wonka of Weed,’ Chuck is a true pioneer of the North American cannabis industry having founded Canopy Growth (formerly Tweed Marijuana) in an dilapidated old Hershey factory and building it into 500,000 square feet of thriving marijuana grow capacity. Today Canopy Growth is worth over $US 200 million and recognized as a worldclass cannabis producer. The talent he recruited now guides the entire Canadian cannabis industry.As CEO of Nesta, Chuck communicates the Company’s vision and purpose, devising practical strategies for sustainable growth and attracting top entrepreneurial talent to the firm.

Investment focus

Cannabis, Lifestyle, Marketing
Series A
Canada

Portfolio highlights

Tokyo Smoke — Tokyo Smoke is a modern lifestyle collective and a cultural movement. Our aim is to create an immersive physical experience, across verticals that touch our hearts, with the care, craft and expertise. Fundamentally, we believe Coffee, Clothing, and Cannabis are the lifeblood of the Creative Class. The Brand Tokyo Smoke is the touchstone for beauty,design, and quality in a society hungry for inclusive but sophisticated, designer brands. The combination of creativity, passion, and originality, has formed a sophisticated urban brand that goes beyond products. By integrating into the creative drivers of consumers, those being coffee, clothing and cannabis, Tokyo Smoke can help shape how today’s individual lives their life. This puts us in a unique position to interact with consumers within multiple touch points throughout their day.Specifically, this is what the verticals allow us to do:• Coffee: the shops function as a brand experience center to host our customers and the community• Clothing: provides a foundation to interact with our customers and ambassadors across the world and to establish the legitimacy and reach of the brand• Cannabis: brings beauty, form and function to an underserved consumer, with Tokyo Smoke as the first brand to provide an aspirational and inspirational lifestyle that transcends the Cannabis cultureCurrently, there are two coffee bars / luxury Cannabis accessory shops that function as experience centers. The line of luxury men’s clothing is available at GotStyle, in the coffee shop as well as other select retailers. The line of Tokyo Smoke Cannabis is soon to be on shelf in Washington State with a first of its kind deal about to be signed in Canada.

John Nemanic

Investment focus

Cannabis, Craft Beer, Food Processing
Seed
Canada

Portfolio highlights

Province Brands of Canada — We are your sustainable and plant-based sweetener solution. We upcycle plant-waste biomass and transform it into food-grade sugars.

Over the course of the last decade, first as a graduate student at Harvard University in the Department of Molecular and Cell Biology with PhD advisor Professor Stuart Schreiber and then as an independent postdoctoral fellow at the Lewis-Sigler Institute at Princeton University, Dr. Ethan Perlstein developed an approach to studying old drugs anddiscovering new drugs in model organisms called evolutionary pharmacology. Ethan is an author on 19 peer-reviewed scholarly publications, including the discovery of a novel mechanism of action for the antidepressant Zoloft based on studies in yeast cells.